Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
[Treatment of neuromyelitis optica].
Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L.
Psychological and physical predictors of illness intrusiveness in patients with multiple sclerosis.
[Vitamin D and neurology.]
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications.
The current role of mitoxantrone in the treatment of multiple sclerosis.
There is still a role for the blink reflex in the diagnosis and follow-up of multiple sclerosis.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
Uhthoff phenomenon in osmotic demyelination syndrome.
Living well with multiple sclerosis.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes.
Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.
Pages
« first
‹ previous
…
540
541
542
543
544
545
546
547
548
…
next ›
last »